Filtros de búsqueda

Lista de obras de

A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

artículo científico publicado en 2013

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

artículo científico publicado en 2016

BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study

scientific article published on 03 December 2020

Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia.

artículo científico publicado en 2018

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project

artículo científico publicado en 2014

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

artículo científico publicado en 2017

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation1 ⬇️

artículo científico publicado el 15 de septiembre de 2003

Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review

artículo científico publicado en 2020

Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status

artículo científico publicado en 2013

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.

artículo científico publicado en 2017

Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research

artículo científico publicado en 2013

Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients

scientific article published on 18 September 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda